News

News

Latest news related to non-animal research

Pro Anima > News
NAMs News - APRIL 06 - 10 2026

Standardizing NAMs, 2025 ECVAM Status Report, Anthropic’s life sciences strategy, Non-clinical safety assessment of vaccines, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Novo Nordisk principal scientist highlights the urgency of advancing human-relevant 3D tissue models As […]

Read more
NAMs News - MARCH 30 - APRIL 03, 2026

UK regulatory guidance for NAMs, Nature collection on organoid models for infectious diseases, AI agents in drug discovery and more

NEWS, REPORTS & POSITION STATEMENTS 1. UK: MHRA published guidance on its approach to medicines developed using non-animal methods The […]

Read more
NAMs News - MARCH 23 - 27, 2026

FDA draft guidance on NAMs for industry, NIH’s $150 million investment, Swiss 3RCC report, PEPPER call for partner laboratories, Cell-Microgel Biohybrid Spheroids, and more

NEWS, REPORTS & POSITION STATEMENTS 1. FDA: General considerations for the use of NAMs in drug development The Food and […]

Read more
NAMs News - MARCH 16 - 20, 2026

Agentic AI in biomedical research, Two decades of iPSC research, Vascularizing OOC, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Agentic AI and the rise of in silico team science in biomedical research Agentic […]

Read more
NAMs News - MARCH 09 - 13, 2026

AI-Ready evaluation for Antimicrobial Resistance Research, BEACON consortium, Bruker x Noetik spatial AI models, iPSC-derived multi-organ PK/PD, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Global community effort to shape new AI-ready datasets and evaluations for Antimicrobial Resistance Research […]

Read more
NAMs News - March 02 - 06, 2026

NAMs Landscape in India, French LIFT Industrial Chair, VISI-ON-BRAIN doctoral network, A human mini-bladder, and more

NEWS, REPORTS & POSITION STATEMENTS 1. India: Landscape analysis on alternatives for drug development The landscape of drug development is […]

Read more
NAMs News - FEBRUARY 23 - 27, 2026

World’s first iPSC-derived drugs approval in Japan, ERA Act, Innovate UK funding, Roche new high-tech center, Human spinal cord organoids, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Japan endorses two iPSC-derived drugs for approval Japan, through a Ministry of Health committee, […]

Read more
NAMs News - FEBRUARY 16 - 20, 2026

Modern risks assessments, Human relevant pre-clinical models, Big pharma’s China deal wave, Intelligent sensors cell production, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Transforming chemicals and cosmetics assessment Carcinogenicity assessment Assessing the safety of chemicals used in […]

Read more
NAMs News - FEBRUARY 09 - 13, 2026

EU IVB competitiveness, IAMPS launch, 2027 DVES Prize call, Industrializing global cell therapy, Big Data and T2 Diabetes, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Strengthening the competitiveness of EU in vitro biotechnologies In vitro biotechnology (IVB) is a […]

Read more
NAMs News - FEBRUARY 02 - 06, 2026

US EPA to replace animal testing by 2035, NATs for Vet research, Advanced human skin models, Brain chips in neurology, and more

NEWS, REPORTS & POSITION STATEMENTS 1. US EPA recommits to eliminate animal testing for chemical safety by 2035 In 2019, the […]

Read more
NAMs News - JANUARY 26 - 30, 2026

AI to assess chemicals, India: AI Center of excellence, The largest dataset for Virtual Cell Modeling, Vascularised organoids, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Challenges and opportunities for human OOC in FDA assessments and pharma pipelines The US […]

Read more
NAMs News - JANUARY 19 - 23, 2026

Animal-free endotoxins test, Common principles for AI, Bioprinted organs on demand, Multi-omics qualification of an OOC model, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Endotoxin testing milestone reached with European Pharmacopoeia’s animal shift From 1 January 2026, EU […]

Read more
Donate
MENU